MEDDAY

At MedDay, they are committed to treating nervous system disorders in areas of high unmet medical need through the elucidation of metabolism pathways in the brain. Their unique clinical and pharmaceutical development expertise in the field of rare inborn errors of metabolism is critical in advancing novel therapeutics for neurological diseases such as multiple sclerosis, autism and Alzheimer’s disease.